MARIJN E DEKKERS
CIK 1216068 · Chief Executive Officer · last filed 2024-08-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$63.97M
Companies
8
Total Filings
84
Lifetime Open-Market Net
-$135.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 5,901,844 | $0.01 | $37.2K | -$2.27M | 8 | 2024-06-14 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 444,609 | $44.96 | $19.99M | -$6.89M | 5 | 2024-06-07 |
| QSI | Director | 650,000 | $0.95 | $615.4K | $0 | 2 | 2022-05-13 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | — | $18.07 | — | $0 | 1 | 2021-06-14 |
| QTRX | Director | 11,031 | $3.10 | $34.2K | -$4.63M | 10 | 2021-06-08 |
| GE | Director | 41,000 | $335.30 | $13.75M | $1.16M | 25 | 2018-04-02 |
| TMO | Chief Executive Officer | 102,814 | $469.34 | $48.25M | -$123.13M | 29 | 2009-08-18 |
| BIIB | Director | 6,595 | $200.05 | $1.32M | $0 | 3 | 2009-06-05 |
Recent Filings · Page 2 of 9
84 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-13 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Grant (A) | +70,921 | $0 | EDGAR |
| 2022-05-13 | QSI | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Grant (A) | +1,746,706 | $0 | EDGAR |
| 2021-09-28 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Exer (M) | +14,270 | $0 | EDGAR |
| 2021-09-20 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Grant (A) | +6,155,324 | $0 | EDGAR |
| 2021-06-14 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | QSI | Grant (A) | +670,512 | $5.00M | EDGAR |
| 2021-06-08 | QTRX | Mixed | −6,810 | -$726.5K | EDGAR |
| 2021-01-13 | QTRX | Mixed | — | -$1.69M | EDGAR |
| 2021-01-05 | QTRX | Grant (A) | +2,270 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.